Press Releases

August 1st, 2023– RevBio Receives FDA Approval to Conduct its Second U.S.-Based Clinical Trial for Dental Implant Stabilization

June 7th, 2023- RevBio is Awarded a $2 Million Grant to Advance the Development of its Novel Dental Adhesive Bone Scaffold Product

May 22nd, 2023- RevBio Receives ISO Certification for its Quality Management Systems

February 14th, 2023- RevBio Receives a Strategic Investment from Pacific Dental Services to Support Ongoing Clinical Trials in Implant Dentistry

January 18th, 2023- RevBio Receives Approval to Start a Dental Clinical Trial in Italy for its Regenerative Biomaterial


December 15th, 2022- A Lowell Biotech will test its ‘bone glue’ in space, Boston Business Journal Article

December 9th, 2022- RevBio Launches an Experiment for its Regenerative Biomaterial on the International Space Station

November 15th, 2022- Novel Bone Adhesive to Fly on SpaceX CRS-26

September 20th, 2022- RevBio Receives NIH Grant to Explore the Treatment of Vertebral Compression Fractures with Its Regenerative Bone Adhesive Technology

September 15th, 2022 — RevBio Receives Approval from the U.K.’s Regulatory Authority to Initiate a Clinical Trial for an Optimized Formulation of its Dental Bone Adhesive Biomaterial


October 25th, 2021– BONEZONE: RevBio Looked Below the Ocean to Find a Way to Treat Bone Fractures

April 6th, 2021 — RevBio Receives a $2 Million NIH Grant to Pursue the Treatment of Wrist Fractures with Its Innovative Bone Adhesive Technology

March 9th, 2021 RevBio Awarded Funding to Conduct an In Vivo Bone Experiment on the International Space Station

February 4th, 2021 — RevBio Enters the Animal Health Market to Help Improve Canine Dental Care


August 4th, 2020 — LaunchPad Medical Rebrands as RevBio and Launches an Updated Website

July 7th, 2020  — LaunchPad Medical Initiates its First European Clinical Study

June 2nd, 2020 — LaunchPad Medical Wins a Coveted $1.8 Million Michigan-Pittsburgh-Wyss Regenerative Medicine Center Grant

May 5th, 2020 — LaunchPad Medical Wins a $2.5 Million NIH Grant to Improve Cranial Procedures 


December 19th, 2019 — LaunchPad Medical Accelerates Enrollment in its First-In-Man Clinical Study

November 6th, 2019 — LaunchPad Medical Wins NIH HEAL Grant to Reduce Opioid Use and Addiction

September 12th, 2019 — LaunchPad Medical Received FDA Approval to Initiate a Clinical Study


June 3rd, 2015– FIERCE BIOTECH: Former Stryker R&D Exec Spins off New Company with Novel Bone Adhesive

June 1st, 2015 –LaunchPad Medical Executives Definitive License Agreement with Stryker for Novel Bone Adhesive Technology

%d bloggers like this: